Cassava Sciences (NASDAQ: SAVA)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Cassava Sciences (NASDAQ: SAVA) through any online brokerage.
The latest price target for Cassava Sciences (NASDAQ: SAVA) was reported by B. Riley Securities on Monday, January 24, 2022. The analyst firm set a price target for 72.00 expecting SAVA to rise to within 12 months (a possible 156.05% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cassava Sciences (NASDAQ: SAVA) is $28.12 last updated Today at June 30, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.
Cassava Sciences’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for Cassava Sciences.
Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.